Feline C-Peptide antibody and antigen (recombinant protein)

 Download 

Product information

Size： 1mg | 10mg | 100mg

Catalog No.	Description	US $ Price (per mg)	First Order Discount	First Order Discount Price
GMP-FEL-C-Peptide-Ag01	Recombinant Feline C-Peptide protein	3090
GMP-FEL-C-Peptide-Ab01	Anti-Feline C-Peptide mouse monoclonal antibody (mAb)	1953	20%	1562.4
GMP-FEL-C-Peptide-Ab02	Anti-Feline C-Peptide mouse monoclonal antibody (mAb)	1953	20%	1562.4
GMP-FEL-C-Peptide-Ab03	Anti-Feline C-Peptide mouse monoclonal antibody (mAb)	1953	20%	1562.4
GMP-FEL-C-Peptide-Ab04	Anti-Feline C-Peptide mouse monoclonal antibody (mAb)	1953	20%	1562.4

Shipping Costs: $360–$760
Antibodies: $360 Antigens: $760 (Elevated cost due to antigen heterogeneity, post-translational modifications, structural complexity, and specialized handling.)

Product Description

Cat No. of Products	GMP-FEL-C-Peptide-Ag01
Product Name	Recombinant Feline C-Peptide protein
Target/Biomarker	Feline C-peptide
Expression platform	E.coli
Isotypes	Recombinant Antigen
Bioactivity validation	Anti-Feline C-peptide antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in level test of animal Cat/Feline with type 1 diabetes mellitus.
Tag	His
Products description	Recombinant Feline C-Peptide protein was expressed in E.coli - based prokaryotic cell expression system and is expressed with 6 HIS tag at the C-terminus.
Purity	Purity: ≥95% (SDS-PAGE)
Application	Paired antibody immunoassay validation in sandwich Elisa, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays
Formulation & Reconstitution	Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O.
Storage	Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Cat No. of Products	GMP-FEL-C-Peptide-Ab01, GMP-FEL-C-Peptide-Ab02, GMP-FEL-C-Peptide-Ab03, GMP-FEL-C-Peptide-Ab04
Product Name	Anti-Feline C-Peptide mouse monoclonal antibody (mAb)
Target/Biomarker	Feline C-peptide
Expression platform	CHO
Isotypes	Mouse IgG
Bioactivity validation	Anti-Feline C-peptide antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in level test of animal Cat/Feline with type 1 diabetes mellitus.
Tag	mFc
Products description	Anti-Feline C-Peptide mouse monoclonal antibody (mAb) was expressed in CHO - based prokaryotic cell expression system and is expressed with 6 HIS tag at the C-terminus.
Purity	Purity: ≥95% (SDS-PAGE)
Application	Paired antibody immunoassay validation in sandwich Elisa, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays
Formulation & Reconstitution	Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O.
Storage	Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference

Validation Data

Click to get more Data / Case study about the product.

Target/Biomarker information

Feline C-Peptide, a remarkable peptide composed of 31 amino acids, is intricately intertwined with the physiological tapestry of cats. It emerges as a critical component of pancreatic function, serving as both a mirror and a marker of endogenous insulin production. C-Peptide is born during the proteolytic cleavage of proinsulin, a precursor to insulin. While insulin takes on the central role in regulating glucose homeostasis, Feline C-Peptide plays a parallel and equally crucial role, co-secreted alongside insulin by the pancreas. Feline C-Peptide follows a pulsatile release pattern into the bloodstream, a pattern that mimics the body's natural insulin secretion. This distinctive feature sets it apart from exogenously administered insulin, which delivers a continuous and uniform dose. As C-Peptide levels rise in response to elevated blood glucose levels, it serves as an invaluable indicator of the pancreas's health and its ability to produce insulin. Beyond its role as a mirror of insulin secretion, Feline C-Peptide plays an essential role in the diagnosis and differentiation of diabetes in cats. This differentiation is not merely a matter of semantics but a pivotal determinant of treatment approaches. Low or undetectable levels of C-Peptide are typically associated with Type 1 diabetes, which results from the autoimmune destruction of pancreatic beta cells, leading to the absence of endogenous insulin production. In contrast, Type 2 diabetes in cats is characterized by varying C-Peptide levels, reflecting a complex interplay of insulin resistance and impaired insulin secretion. The ability to distinguish between these two forms of diabetes guides veterinarians in selecting the most appropriate therapeutic strategies for their feline patients.

About GDU